Chimeric antigen receptor‐modified macrophages trigger systemic anti‐tumour immunity
- 3 November 2020
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 253 (3) , 247-257
Abstract
Preliminary results and emerging data have shown that lipid droplet high (LDhi) immunosuppressive cells accumulate in tumour tissues. By tracking and phenotypic profiling of LDhi cells, we find that LDhiCD19+, LDhiCD11b+, and LDhiLy6G+ immune cell populations appear in the spleen, thymus, and tumour tissues in a syngeneic tumour model. Using a contact‐dependent reporter system, we discover a LDhiCCR7hi immunosuppressive cell population that migrates from tumour tissues to the spleen and thymus. Hence, we engineered a family of chimeric antigen receptor‐modified macrophages (CAR‐Ms) that direct macrophages to CCR7‐positive cells and show that the cytosolic domain from Mer receptor tyrosine kinase (MerTK) triggers tumour cell cytotoxicity by the CAR‐Ms. In vivo, CCR7‐targeted CAR‐Ms suppressed tumour growth and prolonged survival by preventing metastasis and by inducing systemic anti‐tumour immunity through retarding the migration of LDhiCCR7hi immunosuppressive cells from tumour tissues to distal immune organs, indicating an important role for CCR7 in tumour cell‐induced immune tolerance. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
Funding Information
- National Natural Science Foundation of China (81902916, 81903187)
This publication has 28 references indexed in Scilit:
- Progenitors from the central nervous system drive neurogenesis in cancerNature, 2019
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and MemoryCell, 2019
- Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor ProgressionCell, 2018
- Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancerNature Communications, 2017
- Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhighneutrophilsScience, 2017
- Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma ImmunotherapyCancer Cell, 2017
- ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell HomeostasisCell, 2015
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010
- Lipid accumulation and dendritic cell dysfunction in cancerNature Medicine, 2010